本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alterity Therapeutics Limited

3.07
-0.2500-7.53%
成交量:3.44万
成交额:10.79万
市值:5,862.44万
市盈率:-3.33
高:3.34
开:3.21
低:3.04
收:3.32
52周最高:5.89
52周最低:2.66
股本:1,909.59万
流通股本:1,424.34万
量比:1.03
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):-0.9231
每股收益(LYR):-0.9231
净资产收益率:-54.98%
总资产收益率:-34.08%
市净率:1.97
市盈率(LYR):-3.33

数据加载中...

2026/09/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/08/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/09/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/07/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans